ARE YOU DELIVERING ONCOLOGY INNOVATIONS?
WOULD YOU LIKE TO SELL THEM IN JAPAN?
WE CAN HELP!
Our team specializes in bringing together Physicians, Oncology influencers, and industry in Japan.
ARE YOU DELIVERING ONCOLOGY INNOVATIONS?
WOULD YOU LIKE TO SELL THEM IN JAPAN?
WE CAN HELP!
Our team specializes in bringing together Physicians, Oncology influencers, and industry in Japan.
ARE YOU DELIVERING ONCOLOGY INNOVATIONS?
WOULD YOU LIKE TO SELL THEM IN JAPAN?
WE CAN HELP!
Our team specializes in bringing together Physicians, Oncology influencers, and industry in Japan.
ARE YOU DELIVERING ONCOLOGY INNOVATIONS?
WOULD YOU LIKE TO SELL THEM IN JAPAN?
WE CAN HELP!
Our team specializes in bringing together Physicians, Oncology influencers, and industry in Japan.
ARE YOU DELIVERING ONCOLOGY INNOVATIONS?
WOULD YOU LIKE TO SELL THEM IN JAPAN?
WE CAN HELP!
Our team specializes in bringing together Physicians, Oncology influencers, and industry in Japan.
SGLabs' CAAN interviews leading Oncologists and key influencers in Japan.
CAAN is a dynamic force driving innovation in oncology throughout Japan. With the adoption of various technologies such as genome analysis, AI diagnosis, and robotic surgery, cancer treatment is rapidly changing the image of a once-incurable disease.
We aim to bridge the gap between the American oncology industry and top-tier medical professionals, companies, and consumers throughout Japan.
Our team unlocks exciting new oncology opportunities on Japanese soil by facilitating the research and providing the insights needed to thrive in today's market in Japan.
SGLabs' CAAN interviews leading Oncologists and key influencers in Japan.
CAAN is a dynamic force driving innovation in oncology throughout Japan. With the adoption of various technologies such as genome analysis, AI diagnosis, and robotic surgery, cancer treatment is rapidly changing the image of a once-incurable disease.
We aim to bridge the gap between the American oncology industry and top-tier medical professionals, companies, and consumers throughout Japan.
Our team unlocks exciting new oncology opportunities on Japanese soil by facilitating the research and providing the insights needed to thrive in today's market in Japan.
SGLabs' CAAN interviews leading Oncologists and key influencers in Japan.
CAAN is a dynamic force driving innovation in oncology throughout Japan. With the adoption of various technologies such as genome analysis, AI diagnosis, and robotic surgery, cancer treatment is rapidly changing the image of a once-incurable disease.
We aim to bridge the gap between the American oncology industry and top-tier medical professionals, companies, and consumers throughout Japan.
Our team unlocks exciting new oncology opportunities on Japanese soil by facilitating the research and providing the insights needed to thrive in today's market in Japan.
CLINICAL ASSESSMENT & ADVANCEMENT NETWORK (CAAN) Where excellence meets innovation.
At CAAN, we ignite new opportunities and forge relationships between the US and Japan in the oncology market. Our team connects leading doctors and cutting-edge companies with their valued customers throughout Japan.
We work with companies that have FDA approval but are not listed in Japan's National Health Insurance program, and organizations without approved products.
CLINICAL ASSESSMENT & ADVANCEMENT NETWORK (CAAN) Where excellence meets innovation.
At CAAN, we ignite new opportunities and forge relationships between the US and Japan in the oncology market. Our team connects leading doctors and cutting-edge companies with their valued customers throughout Japan.
We work with companies that have FDA approval but are not listed in Japan's National Health Insurance program, and organizations without approved products.
Our Collaborative Approach
We're more than just a bridge; with a network of cancer treatment specialists at our side, we bring together both Japanese and, at times, international medical enterprises to help achieve our clients' goals. This dynamic collaboration fuels the creation of groundbreaking innovations and lucrative business prospects.
Unlock the CAAN Advantage
Unlock the CAAN Advantage
Unlock the CAAN Advantage
Unlock the CAAN Advantage
Unlock the CAAN Advantage
Pioneering New Ventures: We don't just do research; we cultivate success stories, ensuring the brands we represent in Japan thrive in this competitive landscape.
Enhancing Existing Enterprises: We bring growth to established ventures, making them even more robust.
Empowering Doctors and Patients: We're committed to elevating healthcare standards and enriching the experiences of medical professionals and patients alike.
Pioneering New Ventures: We don't just do research; we cultivate success stories, ensuring the brands we represent in Japan thrive in this competitive landscape.
Enhancing Existing Enterprises: We bring growth to established ventures, making them even more robust.
Empowering Doctors and Patients: We're committed to elevating healthcare standards and enriching the experiences of medical professionals and patients alike.
Pioneering New Ventures: We don't just do research; we cultivate success stories, ensuring the brands we represent in Japan thrive in this competitive landscape.
Enhancing Existing Enterprises: We bring growth to established ventures, making them even more robust.
Empowering Doctors and Patients: We're committed to elevating healthcare standards and enriching the experiences of medical professionals and patients alike.
SOME OF THE ONCOLOGY SOLUTIONS WE ARE SEEKING INCLUDE:
Successful marketing strategies from 2019 will not work today.
SOME OF THE ONCOLOGY SOLUTIONS WE ARE SEEKING INCLUDE:
DRUGS
DRUGS
TESTING
LIFESTYLES
LIFESTYLES
DEVICES
TRUST
SERVICES
SERVICES
COMPETITION
SERVICES
TECHNOLOGIES
TECHNOLOGIES
TECHNOLOGIES
ETC
ETC
WHY WORK WITH US?
At CAAN, our foundation rests upon a robust network of 80 dedicated cancer specialists. In 2019, our team joined the 22nd Century Advanced Medical Information Institute (CEMIT) to organize a medical symposium focused on "cancer genomic medicine." CEMIT adds another 97 Japanese facilities, and 1,073 Japanese doctors we may call on to answer our customers' or partners' questions.
A Legacy of Collaboration
In recent years, our teams' commitment has extended to lectures and research projects in partnership with renowned institutions such as the National Cancer Center Hospital East, the Japanese Society of Clinical Oncology (JSMO), the American Society of Clinical Oncology (ASCO), and many others. Our team also participates in the cancer genome screening project, SCRUM-Japan.
WHY WORK WITH US?
At CAAN, our foundation rests upon a robust network of 80 dedicated cancer specialists. In 2019, our team joined the 22nd Century Advanced Medical Information Institute (CEMIT) to organize a medical symposium focused on "cancer genomic medicine." CEMIT adds another 97 Japanese facilities, and 1,073 Japanese doctors we may call on to answer our customers' or partners' questions.
A Legacy of Collaboration
In recent years, our teams' commitment has extended to lectures and research projects in partnership with renowned institutions such as the National Cancer Center Hospital East, the Japanese Society of Clinical Oncology (JSMO), the American Society of Clinical Oncology (ASCO), and many others. Our team also participates in the cancer genome screening project, SCRUM-Japan.
Partnerships & Achievements
Partnerships & Achievements
Partnerships and Achievements
Partnerships & Achievements
- Japanese Domestic Partnerships: National Cancer Center Hospital East, JSMO (Japanese Society of Clinical Oncology)
- Global Outreach: ASCO (American Society of Clinical Oncology) *ASCO Breakthrough 2023, ESMO (European Society of Medical Oncology) *Various Guideline Meetings
- CEMIT Collaboration: Co-hosting medical symposia on "cancer genome medicine" since 2019
- Pharmaceutical and Medical Industry: Collaborations with over 20 domestic and international pharmaceutical, medical device, and medical testing companies.
- Japanese Domestic Partnerships: National Cancer Center Hospital East, JSMO (Japanese Society of Clinical Oncology)
- Global Outreach: ASCO (American Society of Clinical Oncology) *ASCO Breakthrough 2023, ESMO (European Society of Medical Oncology) *Various Guideline Meetings
- CEMIT Collaboration: Co-hosting medical symposia on "cancer genome medicine" since 2019
- Pharmaceutical and Medical Industry: Collaborations with over 20 domestic and international pharmaceutical, medical device, and medical testing companies.
A multi-modal approach illuminates essential perspectives and associations.
By overlaying data between multiple testing modalities, including explicit research (surveys) and cognitive / implicit research (fast choice), we can measure participants' strength of associations to various attributes, such as brands and products. We can gain perspective on what medical professionals, specialists, and consumers think and why.
For example, in Implicit testing, a brand may find a strong association with consumers desiring their product. However, when combined with survey responses, there is a high price perception. So, the brand knows there is a desire for their product, but they must overcome a value perception issue.
A multi-modal approach illuminates essential perspectives and associations.
By overlaying the data between modalities and showing how panelists with strong associations to attributes respond to Explicit research, such as survey questions and Cognitive research - Implicit/Fast Choice tasks, we can gain perspective on what medical professionals, specialists, and consumers think and why.
For example, in Implicit testing, a brand may find a strong association with consumers desiring their product. However, when combined with survey responses, there is a high price perception. So, the brand knows there is a desire for their product, but they must overcome a value perception issue.
Multi-modal Research Methodology
MULTI-MODAL RESEARCH METHODOLOGY
MULTI-MODAL RESEARCH METHODOLOGY
SOME ADDITIONAL SERVICES WE PROVIDE
SOME ADDITIONAL SERVICES WE PROVIDE
SOME ADDITIONAL SERVICES WE PROVIDE
To succeed in Japan, companies need to do business in a "Japanese way". With our deep on-shore network of clients and partners, we can ensure that everyone communicates and is on the same page within this structure. This helps all stakeholders achieve their goals in Japan.
When our team brings American companies to Japan, we find the right partners and use our research platform to ensure results are easy to understand and explain to others. Drawing powerful insights and displaying them in an easily understood way helps senior executives make the best decisions they can to do business and accomplish their goals in Japan.
- Explicit and Implicit research and insights are delivered, via an easy-to-use dashboard.
- Japanese content development (written by a native-speaking Japanese)
- Videos, booklets, seminars, press, digital assets, and conferences
- Please see the CAAN interview on our Japanese medical series Pivot (Highlighted at the top of this page).
To succeed in Japan, American companies need to do business in a "Japanese way," and we can ensure that everyone we work with communicates and is on the same page within this structure, which helps all stakeholders achieve their goals in Japan.
When our team brings American companies to Japan, we find the right partners and use our research platform to ensure reporting our research results is easy to understand and explain to others. Drawing powerful insights and displaying them in an easily understood way helps senior executives make the best decisions they can to do business and accomplish their goals in Japan.
- Explicit and Implicit research and insights are delivered, via an easy-to-use Tableau-based dashboard.
- Japanese content development (written by a native-speaking Japanese)
- Videos, booklets, seminars, press, digital assets, and conferences
- CAAN interview on our hit Japanese series Pivot (Highlighted at the top of this page).
To succeed in Japan, American companies need to do business in a "Japanese way," and we can ensure that everyone we work with communicates and is on the same page within this structure, which helps all stakeholders achieve their goals in Japan.
When our team brings American companies to Japan, we find the right partners and use our research platform to ensure reporting our research results is easy to understand and explain to others. Drawing powerful insights and displaying them in an easily understood way helps senior executives make the best decisions they can to do business and accomplish their goals in Japan.
- Explicit and Implicit research and insights are delivered, via an easy-to-use Tableau-based dashboard.
- Japanese content development (written by a native-speaking Japanese)
- Videos, booklets, seminars, press, digital assets, and conferences
- CAAN interview on our hit Japanese series Pivot (Highlighted at the top of this page).
To succeed in Japan, American companies need to do business in a "Japanese way," and we can ensure that everyone we work with communicates and is on the same page within this structure, which helps all stakeholders achieve their goals in Japan.
When our team brings American companies to Japan, we find the right partners and use our research platform to ensure reporting our research results is easy to understand and explain to others. Drawing powerful insights and displaying them in an easily understood way helps senior executives make the best decisions they can to do business and accomplish their goals in Japan.
- Explicit and Implicit research and insights are delivered, via an easy-to-use Tableau-based dashboard.
- Japanese content development (written by a native-speaking Japanese individual)
- Videos, booklets, seminars, press, digital assets, and conferences.
- CAAN interview on our hit Japanese series Pivot (Highlighted at the top of this page).
Visit our offices in Japan
MetLife Kanda Nishikicho Building 4F, 3-23 Kanda Nishikicho, Chiyoda-ku,
Tokyo 101-0054
Visit our offices in Japan
MetLife Kanda Nishikicho Building 4F, 3-23 Kanda Nishikicho, Chiyoda-ku, Tokyo 101-0054
Visit our offices in Japan
MetLife Kanda Nishikicho Building 4F, 3-23 Kanda Nishikicho, Chiyoda-ku, Tokyo 101-0054
Join Our Mailing List
Located in Denver, CO
© 2023 Sleeping Giant Solutions, LLC.
All trademarks mentioned belong to their owners, corporate & company names are registered trademarks of their respective companies and are used for purposes of explanation, without implying a violation of copyright law.